SYK - Strategic Sale: Glenn S Boehnlein Decides To Exercise Options Worth $13.02M At Stryker | Benzinga
In a new SEC filing on January 16, it was revealed that Boehnlein, VP at Stryker (NYSE:SYK), executed a significant exercise of company stock options.
What Happened: Boehnlein, VP at Stryker, exercised stock options for 60,005 shares of SYK stock. This information was disclosed in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday. The exercise price of the options was $95.99 per share.
As of Wednesday morning, Stryker shares are down by 0.41%, with a current price of $313.01. This implies that Boehnlein's 60,005 shares have a value of $13,022,142.
All You Need to Know About Stryker
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.
Stryker: Delving into Financials
Revenue Growth: Stryker's remarkable performance in 3 months is evident. As of 30 September, 2023, the company achieved an impressive revenue growth ...